Although most safety outcomes did not reach statistical significance, adverse events generally tended to occur less frequently with ISA than with other antifungal agents.
← all excerpts
Efficacy and safety of isavuconazole for invasive fungal infections: A systematic review and meta-analysis of randomized controlled trials.
1
—
—